Skip to main content

Advertisement

SpringerLink
Log in

The thymus, thymoma and myasthenia gravis

  • Review Article
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Myasthenia gravis is an autoimmune disease. An autoantibody directed toward acetylcholine receptor (AChR) causes the destruction of the postsynaptic membrane and a reduction of the number of AChRs at neuromuscular junctions. A very puzzling, but interesting characteristic of myasthenia gravis is that many of the patients have an abnormality in their thymus. Many have a hyperplastic thymus with germinal centers, while others have a thymic tumor. How is the abnormality of the thymus related to myasthenia gravis? This review will summarize the existing evidence and try to find the missing link between the thymus and myasthenia gravis. The review will also comment on two distinct populations of myasthenia gravis patients without thymoma. The autoimmunity found in elderly patients is nonspecific and initiated via a different mechanism from the initiation of myasthenia gravis in younger patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Ohata N, Usami N, Kawaguchi K, Tateyama H, Yokoi K. Type AB thymoma with brain metastasis: report of a case. Surg Today. 2011;41:1436–8.

    Article  PubMed  Google Scholar 

  2. Okumura M, Miyoshi S, Fujii Y, Takeuchi Y, Shiono H, Inoue M, et al. Clinical and functional significance of WHO classification on human thymic epithelial neoplasms: a study of 146 consecutive tumors. Am J Surg Pathol. 2001;25:103–10.

    Article  PubMed  CAS  Google Scholar 

  3. Lindstrom J, Shelton D, Fujii Y. Myasthenia gravis. Adv Immunol. 1988;42:233–84.

    Article  PubMed  CAS  Google Scholar 

  4. Okumura M, Fujii Y, Shiono H, Inoue M, Minami M, Utsumi T, Kadota Y, Sawa Y. Immunological function of thymoma and pathogenesis of paraneoplastic myasthenia gravis. Gen Thorac Cardiovasc Surg. 2008;56:143–50.

    Article  PubMed  Google Scholar 

  5. Zuklys S, Balciunaite G, Agarwal A, FaslerKan E, Palmer E, Hollander GA. Normal thymic architecture and negative selection are associated with Aire expression, the gene defective in the autoimmune-polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). J Immunol. 2000;165:1976–83.

    PubMed  CAS  Google Scholar 

  6. Buckley C, Douek D, NewsomDavis J, Vincent A, Willcox N. Mature, long-lived CD4(+) and CD8(+) T cells are generated by the thymoma in myasthenia gravis. Ann Neurol. 2001;50:64–72.

    Article  PubMed  CAS  Google Scholar 

  7. Grau JM, Casademont J, Monforte R, Marin P, Granena A, Rozman C, Urbano-Marquez A. Myasthenia gravis after allogeneic bone marrow transplantation: report of a new case and pathogenetic considerations. Bone Marrow Transplant. 1990;5:435–7.

    PubMed  CAS  Google Scholar 

  8. Nakagiri T, Okumura M, Inoue M, Minami M, Kiyohara E, Umegaki N, Nakamura T, Tomita Y, Katayama I, Aozasa K. Thymoma-associated graft-versus-host disease-like erythroderma. J Thorac Oncol. 2007;2:1130–2.

    Article  PubMed  Google Scholar 

  9. Vernino S, Lennon VA. Autoantibody profiles and neurological correlations of thymoma. Clin Cancer Res. 2004;10:7270–5.

    Article  PubMed  CAS  Google Scholar 

  10. Villasenor J, Besse W, Benoist C, Mathis D. Ectopic expression of peripheral-tissue antigens in the thymic epithelium: probabilistic, monoallelic, misinitiated. Proc Natl Acad Sci USA. 2008;105:15854–9.

    Article  PubMed  CAS  Google Scholar 

  11. Suzuki E, Kobayashi Y, Yano M, Fujii Y. Infrequent and low AIRE expression in thymoma: difference in AIRE expression among WHO subtypes does not correlate with association of MG. Autoimmunity. 2008;41:377–82.

    Article  PubMed  CAS  Google Scholar 

  12. Suzuki S, Utsugisawa K, Yoshikawa H, Motomura M, Matsubara S, Yokoyama K, Nagane Y, Maruta T, Satoh T, Sato H, Kuwana M, Suzuki N. Autoimmune targets of heart and skeletal muscles in myasthenia gravis. Arch Neurol. 2009;66:1334–8.

    Article  PubMed  Google Scholar 

  13. Hoch W, McConville J, Helms S, NewsomDavis J, Melms A, Vincent A. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nature Med. 2001;7:365–8.

    Article  PubMed  CAS  Google Scholar 

  14. Fujii Y, Monden Y, Nakahara K, Hashimoto Y, Kawashima Y. Antibody to acetylcholine receptor in myasthenia gravis: production by lymphocytes from thymus or thymoma. Neurology. 1984;34:1182–6.

    Article  PubMed  CAS  Google Scholar 

  15. Sims GP, Shiono H, Willcox N, Stott DI. Somatic hypermutation and selection of B cells in thymic germinal centers responding to acetylcholine receptor in myasthenia gravis. J Immunol. 2001;167:1935–44.

    PubMed  CAS  Google Scholar 

  16. Hill ME, Shiono H, Newsom-Davis J, Willcox N. The myasthenia gravis thymus: a rare source of human autoantibody-secreting plasma cells for testing potential therapeutics. J Neuroimmunol. 2008;201–202:50–6.

    Article  PubMed  Google Scholar 

  17. Fujii Y, Hashimoto J, Monden Y, Ito T, Nakahara K, Kawashima Y. Specific activation of lymphocytes against acetylcholine receptor in the thymus in myasthenia gravis. J Immunol. 1986;136:887–91.

    PubMed  CAS  Google Scholar 

  18. Nicolle MW. Pseudo-myasthenia gravis and thymic hyperplasia in Graves’ disease. Can J Neurol Sci. 1999;26:201–3.

    PubMed  CAS  Google Scholar 

  19. Nakajima J, Murakawa T, Fukami T, Sano A, Takamoto S, Ohtsu H. Postthymectomy myasthenia gravis: relationship with thymoma and antiacetylcholine receptor antibody. Ann Thorac Surg. 2008;86:941–5.

    Article  PubMed  Google Scholar 

  20. Yamamoto AM, Gajdos P, Eymard B, Tranchant C, Warter JM, Gomez L, Bourquin C, Bach JF, Garchon HJ. Anti-titin antibodies in myasthenia gravis: tight association with thymoma and heterogeneity of nonthymoma patients. Arch Neurol. 2001;58:885–90.

    Article  PubMed  CAS  Google Scholar 

  21. Somnier FE, Engel PJH. The occurrence of anti-titin antibodies and thymomas—a population survey of MG 1970–1999. Neurology. 2002;59:92–8.

    Article  PubMed  Google Scholar 

  22. Vincent A, Clover L, Buckley C, Evans JG, Rothwell PM. Evidence of underdiagnosis of myasthenia gravis in older people. J Neurol Neurosurg Psychiatry. 2003;74:1105–8.

    Article  PubMed  CAS  Google Scholar 

  23. Berer K, Mues M, Koutrolos M, Rasbi ZA, Boziki M, Johner C, Wekerle H, Krishnamoorthy G. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature. 2011;479:538–41.

    Article  PubMed  CAS  Google Scholar 

  24. Melms A, Malcherek G, Gern U, Wietholter H, Muller CA, Schopfer R, Lindstrom J. T cells from normal and myasthenic individuals recognize the human acetylcholine receptor: heterogeneity of antigenic sites on the alpha-subunit. Ann Neurol. 1992;31:311–8.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

The author has no conflicts of interest to declare.

Author information

Authors and Affiliations

  1. Department of Oncology, Immunology, and Surgery, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-ku, Nagoya, 467-8601, Japan

    Yoshitaka Fujii

Authors
  1. Yoshitaka Fujii
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yoshitaka Fujii.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fujii, Y. The thymus, thymoma and myasthenia gravis. Surg Today 43, 461–466 (2013). https://doi.org/10.1007/s00595-012-0318-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-012-0318-2

Keywords

Search

Navigation